Rick Scalzo
Directeur Financier/CFO chez DYNE THERAPEUTICS, INC.
Fortune : 4 M $ au 31/05/2024
Profil
Rick Scalzo's current job is Senior Vice President-Finance & Administration at Dyne Therapeutics, Inc. His former jobs include being a Controller at Astellas Institute for Regenerative Medicine in 2014, Chief Accounting Officer at Kaleido Biosciences, Inc. in 2019, and Controller at X4 Pharmaceuticals, Inc. from 2016 to 2018.
He completed his undergraduate degree at Boston College in 2008 and earned an MBA from the University of Massachusetts in 2016.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DYNE THERAPEUTICS INC
0,12% | 16/05/2024 | 116 695 ( 0,12% ) | 4 M $ | 31/05/2024 |
Postes actifs de Rick Scalzo
| Sociétés | Poste | Début |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Directeur Financier/CFO | 01/07/2020 |
Anciens postes connus de Rick Scalzo
| Sociétés | Poste | Fin |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 29/11/2019 |
| X4 PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/08/2018 |
| OCATA THERAPEUTICS INC | Comptroller/Controller/Auditor | 01/09/2014 |
Formation de Rick Scalzo
| University of Massachusetts | Masters Business Admin |
| Boston College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
